Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2022

01-04-2022 | Macroalbuminuria | IM - ORIGINAL

Low eGFR and albuminuria independently predict all-cause mortality in high-risk subjects undergoing coronary arteriography

Authors: Maria Maddalena D’Errico, Pamela Piscitelli, Antonio Mirijello, Mariateresa Santoliquido, Valentina Massa, Mauro Salvatori, Carlo Vigna, Gianluigi Vendemiale, Filippo Aucella, Roberto Pontremoli, Salvatore A. De Cosmo

Published in: Internal and Emergency Medicine | Issue 3/2022

Login to get access

Abstract

Individuals with Chronic Kidney Disease (CKD) are at high risk for cardiovascular morbidity and mortality. The aim of this study was to examine the relationship between renal dysfunction and all-cause mortality in a sample of subjects undergoing coronary angiography (CA). We evaluated 1017 subjects who consecutively underwent CA. Glomerular filtration rate (eGFR) was estimated by CKD-EPI and urinary albumin excretion reported as urinary albumin-to-creatinine ratio. Vital status was ascertained by interrogating the Italian Health Card Database. One-thousand-seventeen subjects (759 M/258F) were enrolled into the study from 2016 to 2018. One-hundred-fourteen deaths occurred during a median follow-up of 44 months. The whole population was divided in two subgroups according to the presence/absence of low eGFR (i.e. < 60 ml/min/1.73 m2). Subjects with low baseline eGFR had a worse clinical profile than subjects with preserved kidney function. The risk of death in subjects with eGFR < 60 ml/min/1.73 m2 was almost three times higher than in subjects with preserved kidney function: fully adjusted HR 2.70 (95% CI 1.56–4.67). The presence of albuminuria also predicted a high risk of death: fully adjusted HR 2.09 (95% CI 1.17–3.73) and HR 4.26 (95% CI 2.18–8.33), microalbuminuria or macroalbuminuria, respectively, being normoalbuminuria the reference group. Again, the increased risk remained significant after adjusting for several potential confounders. In conclusion, kidney disease measures (i.e. low eGFR or albuminuria) independently predict increased risk for all-cause death in a large sample of subjects undergoing CA. These results have a relevant clinical impact.
Literature
2.
24.
go back to reference Peto R (1976) Two properties of multiple regression analysis, and regression to the mean (and regression from the mean). In: Fletcher CM, Peto R, Tinker CM, Speizer FE (eds) The natural history of chronic bronchitis and emphysema. An eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, Oxford, pp 218–223 Peto R (1976) Two properties of multiple regression analysis, and regression to the mean (and regression from the mean). In: Fletcher CM, Peto R, Tinker CM, Speizer FE (eds) The natural history of chronic bronchitis and emphysema. An eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, Oxford, pp 218–223
Metadata
Title
Low eGFR and albuminuria independently predict all-cause mortality in high-risk subjects undergoing coronary arteriography
Authors
Maria Maddalena D’Errico
Pamela Piscitelli
Antonio Mirijello
Mariateresa Santoliquido
Valentina Massa
Mauro Salvatori
Carlo Vigna
Gianluigi Vendemiale
Filippo Aucella
Roberto Pontremoli
Salvatore A. De Cosmo
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2022
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-021-02851-4

Other articles of this Issue 3/2022

Internal and Emergency Medicine 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.